+1 347 708 0418
The Metabotropic Glutamate Receptor 5 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Metabotropic Glutamate Receptor 5 size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Metabotropic Glutamate Receptor 5 market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Metabotropic Glutamate Receptor 5 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Alloswitch-1
BMS-952048
BMS-955829
Dipraglurant ER
Others
Market segment by Application can be divided into
Major Depressive Disorder
Alcohol Addiction
Alzheimer's Disease
Others
The key market players for global Metabotropic Glutamate Receptor 5 market are listed below:
Addex Therapeutics Ltd
Aevi Genomic Medicine Inc
Bristol-Myers Squibb Company
Eisai Co Ltd
Eli Lilly and Company
Heptares Therapeutics Ltd
Johnson & Johnson
Merz Pharma GmbH & Co KgaA
Novartis AG
Richter Gedeon Nyrt
Sumitomo Dainippon Pharma Co Ltd
Toray Industries Inc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Metabotropic Glutamate Receptor 5 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Metabotropic Glutamate Receptor 5, with price, sales, revenue and global market share of Metabotropic Glutamate Receptor 5 from 2019 to 2021.
Chapter 3, the Metabotropic Glutamate Receptor 5 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metabotropic Glutamate Receptor 5 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Metabotropic Glutamate Receptor 5 market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Metabotropic Glutamate Receptor 5 sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Metabotropic Glutamate Receptor 5 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Metabotropic Glutamate Receptor 5 Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Alloswitch-1
1.2.3 BMS-952048
1.2.4 BMS-955829
1.2.5 Dipraglurant ER
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Metabotropic Glutamate Receptor 5 Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Major Depressive Disorder
1.3.3 Alcohol Addiction
1.3.4 Alzheimer's Disease
1.3.5 Others
1.4 Global Metabotropic Glutamate Receptor 5 Market Size & Forecast
1.4.1 Global Metabotropic Glutamate Receptor 5 Sales in Value (2016-2026))
1.4.2 Global Metabotropic Glutamate Receptor 5 Sales in Volume (2016-2026)
1.4.3 Global Metabotropic Glutamate Receptor 5 Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Metabotropic Glutamate Receptor 5 Production Capacity Analysis
1.5.1 Global Metabotropic Glutamate Receptor 5 Total Production Capacity (2016-2026)
1.5.2 Global Metabotropic Glutamate Receptor 5 Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Metabotropic Glutamate Receptor 5 Market Drivers
1.6.2 Metabotropic Glutamate Receptor 5 Market Restraints
1.6.3 Metabotropic Glutamate Receptor 5 Trends Analysis
2 Manufacturers Profiles
2.1 Addex Therapeutics Ltd
2.1.1 Addex Therapeutics Ltd Details
2.1.2 Addex Therapeutics Ltd Major Business
2.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product and Services
2.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Aevi Genomic Medicine Inc
2.2.1 Aevi Genomic Medicine Inc Details
2.2.2 Aevi Genomic Medicine Inc Major Business
2.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product and Services
2.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Bristol-Myers Squibb Company
2.3.1 Bristol-Myers Squibb Company Details
2.3.2 Bristol-Myers Squibb Company Major Business
2.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product and Services
2.3.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Eisai Co Ltd
2.4.1 Eisai Co Ltd Details
2.4.2 Eisai Co Ltd Major Business
2.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product and Services
2.4.4 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Eli Lilly and Company
2.5.1 Eli Lilly and Company Details
2.5.2 Eli Lilly and Company Major Business
2.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product and Services
2.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Heptares Therapeutics Ltd
2.6.1 Heptares Therapeutics Ltd Details
2.6.2 Heptares Therapeutics Ltd Major Business
2.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product and Services
2.6.4 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Product and Services
2.7.4 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Merz Pharma GmbH & Co KgaA
2.8.1 Merz Pharma GmbH & Co KgaA Details
2.8.2 Merz Pharma GmbH & Co KgaA Major Business
2.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product and Services
2.8.4 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business
2.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Product and Services
2.9.4 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Richter Gedeon Nyrt
2.10.1 Richter Gedeon Nyrt Details
2.10.2 Richter Gedeon Nyrt Major Business
2.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product and Services
2.10.4 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Sumitomo Dainippon Pharma Co Ltd
2.11.1 Sumitomo Dainippon Pharma Co Ltd Details
2.11.2 Sumitomo Dainippon Pharma Co Ltd Major Business
2.11.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product and Services
2.11.4 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Toray Industries Inc
2.12.1 Toray Industries Inc Details
2.12.2 Toray Industries Inc Major Business
2.12.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Product and Services
2.12.4 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Metabotropic Glutamate Receptor 5 Sales by Manufacturer
3.1 Global Metabotropic Glutamate Receptor 5 Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Metabotropic Glutamate Receptor 5
3.4 Market Concentration Rate
3.4.1 Top 3 Metabotropic Glutamate Receptor 5 Manufacturer Market Share
3.4.2 Top 6 Metabotropic Glutamate Receptor 5 Manufacturer Market Share
3.5 Global Metabotropic Glutamate Receptor 5 Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Metabotropic Glutamate Receptor 5 Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Metabotropic Glutamate Receptor 5 Market Size by Region
4.1.1 Global Metabotropic Glutamate Receptor 5 Sales in Volume by Region (2016-2026)
4.1.2 Global Metabotropic Glutamate Receptor 5 Revenue by Region (2016-2026)
4.2 North America Metabotropic Glutamate Receptor 5 Revenue (2016-2026)
4.3 Europe Metabotropic Glutamate Receptor 5 Revenue (2016-2026)
4.4 Asia-Pacific Metabotropic Glutamate Receptor 5 Revenue (2016-2026)
4.5 South America Metabotropic Glutamate Receptor 5 Revenue (2016-2026)
4.6 Middle East and Africa Metabotropic Glutamate Receptor 5 Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Metabotropic Glutamate Receptor 5 Sales in Volume by Type (2016-2026)
5.2 Global Metabotropic Glutamate Receptor 5 Revenue by Type (2016-2026)
5.3 Global Metabotropic Glutamate Receptor 5 Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Metabotropic Glutamate Receptor 5 Sales in Volume by Application (2016-2026)
6.2 Global Metabotropic Glutamate Receptor 5 Revenue by Application (2016-2026)
6.3 Global Metabotropic Glutamate Receptor 5 Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Metabotropic Glutamate Receptor 5 Sales by Type (2016-2026)
7.2 North America Metabotropic Glutamate Receptor 5 Sales by Application (2016-2026)
7.3 North America Metabotropic Glutamate Receptor 5 Market Size by Country
7.3.1 North America Metabotropic Glutamate Receptor 5 Sales in Volume by Country (2016-2026)
7.3.2 North America Metabotropic Glutamate Receptor 5 Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Metabotropic Glutamate Receptor 5 Sales by Type (2016-2026)
8.2 Europe Metabotropic Glutamate Receptor 5 Sales by Application (2016-2026)
8.3 Europe Metabotropic Glutamate Receptor 5 Market Size by Country
8.3.1 Europe Metabotropic Glutamate Receptor 5 Sales in Volume by Country (2016-2026)
8.3.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Type (2016-2026)
9.2 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Application (2016-2026)
9.3 Asia-Pacific Metabotropic Glutamate Receptor 5 Market Size by Region
9.3.1 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Metabotropic Glutamate Receptor 5 Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Metabotropic Glutamate Receptor 5 Sales by Type (2016-2026)
10.2 South America Metabotropic Glutamate Receptor 5 Sales by Application (2016-2026)
10.3 South America Metabotropic Glutamate Receptor 5 Market Size by Country
10.3.1 South America Metabotropic Glutamate Receptor 5 Sales in Volume by Country (2016-2026)
10.3.2 South America Metabotropic Glutamate Receptor 5 Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Type (2016-2026)
11.2 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Application (2016-2026)
11.3 Middle East & Africa Metabotropic Glutamate Receptor 5 Market Size by Country
11.3.1 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Metabotropic Glutamate Receptor 5 Typical Distributors
12.3 Metabotropic Glutamate Receptor 5 Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Metabotropic Glutamate Receptor 5 Revenue by Type, (USD Million), 2021-2026
Table 2. Global Metabotropic Glutamate Receptor 5 Revenue by Application, (USD Million), 2021-2026
Table 3. Addex Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 4. Addex Therapeutics Ltd Major Business
Table 5. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product and Services
Table 6. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Aevi Genomic Medicine Inc Basic Information, Manufacturing Base and Competitors
Table 8. Aevi Genomic Medicine Inc Major Business
Table 9. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product and Services
Table 10. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 12. Bristol-Myers Squibb Company Major Business
Table 13. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product and Services
Table 14. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Eisai Co Ltd Basic Information, Manufacturing Base and Competitors
Table 16. Eisai Co Ltd Major Business
Table 17. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product and Services
Table 18. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 20. Eli Lilly and Company Major Business
Table 21. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product and Services
Table 22. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Heptares Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Heptares Therapeutics Ltd Major Business
Table 25. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product and Services
Table 26. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 28. Johnson & Johnson Major Business
Table 29. Johnson & Johnson Metabotropic Glutamate Receptor 5 Product and Services
Table 30. Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Merz Pharma GmbH & Co KgaA Basic Information, Manufacturing Base and Competitors
Table 32. Merz Pharma GmbH & Co KgaA Major Business
Table 33. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product and Services
Table 34. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 36. Novartis AG Major Business
Table 37. Novartis AG Metabotropic Glutamate Receptor 5 Product and Services
Table 38. Novartis AG Metabotropic Glutamate Receptor 5 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Richter Gedeon Nyrt Basic Information, Manufacturing Base and Competitors
Table 40. Richter Gedeon Nyrt Major Business
Table 41. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product and Services
Table 42. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Sumitomo Dainippon Pharma Co Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Sumitomo Dainippon Pharma Co Ltd Major Business
Table 45. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product and Services
Table 46. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Toray Industries Inc Basic Information, Manufacturing Base and Competitors
Table 48. Toray Industries Inc Major Business
Table 49. Toray Industries Inc Metabotropic Glutamate Receptor 5 Product and Services
Table 50. Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global Metabotropic Glutamate Receptor 5 Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 52. Global Metabotropic Glutamate Receptor 5 Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in Metabotropic Glutamate Receptor 5, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global Metabotropic Glutamate Receptor 5 Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 55. Head Office and Metabotropic Glutamate Receptor 5 Production Site of Key Manufacturer
Table 56. Metabotropic Glutamate Receptor 5 New Entrant and Capacity Expansion Plans
Table 57. Metabotropic Glutamate Receptor 5 Mergers & Acquisitions in the Past Five Years
Table 58. Global Metabotropic Glutamate Receptor 5 Sales by Region (2016-2021e) & (K Pcs)
Table 59. Global Metabotropic Glutamate Receptor 5 Sales by Region (2021-2026) & (K Pcs)
Table 60. Global Metabotropic Glutamate Receptor 5 Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global Metabotropic Glutamate Receptor 5 Revenue by Region (2021-2026) & (USD Million)
Table 62. Global Metabotropic Glutamate Receptor 5 Sales by Type (2016-2021e) & (K Pcs)
Table 63. Global Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (K Pcs)
Table 64. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2021-2026) & (USD Million)
Table 66. Global Metabotropic Glutamate Receptor 5 Price by Type (2016-2021e) & (USD/Pcs)
Table 67. Global Metabotropic Glutamate Receptor 5 Price by Type (2021-2026) & (USD/Pcs)
Table 68. Global Metabotropic Glutamate Receptor 5 Sales by Application (2016-2021e) & (K Pcs)
Table 69. Global Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (K Pcs)
Table 70. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2021-2026) & (USD Million)
Table 72. Global Metabotropic Glutamate Receptor 5 Price by Application (2016-2021e) & (USD/Pcs)
Table 73. Global Metabotropic Glutamate Receptor 5 Price by Application (2021-2026) & (USD/Pcs)
Table 74. North America Metabotropic Glutamate Receptor 5 Sales by Country (2016-2021e) & (K Pcs)
Table 75. North America Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (K Pcs)
Table 76. North America Metabotropic Glutamate Receptor 5 Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America Metabotropic Glutamate Receptor 5 Revenue by Country (2021-2026) & (USD Million)
Table 78. North America Metabotropic Glutamate Receptor 5 Sales by Type (2016-2021e) & (K Pcs)
Table 79. North America Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (K Pcs)
Table 80. North America Metabotropic Glutamate Receptor 5 Sales by Application (2016-2021e) & (K Pcs)
Table 81. North America Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (K Pcs)
Table 82. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2016-2021e) & (K Pcs)
Table 83. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (K Pcs)
Table 84. Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2016-2021e) & (K Pcs)
Table 87. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (K Pcs)
Table 88. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2016-2021e) & (K Pcs)
Table 89. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (K Pcs)
Table 90. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Region (2016-2021e) & (K Pcs)
Table 91. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Region (2021-2026) & (K Pcs)
Table 92. Asia-Pacific Metabotropic Glutamate Receptor 5 Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific Metabotropic Glutamate Receptor 5 Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Type (2016-2021e) & (K Pcs)
Table 95. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (K Pcs)
Table 96. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Application (2016-2021e) & (K Pcs)
Table 97. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (K Pcs)
Table 98. South America Metabotropic Glutamate Receptor 5 Sales by Country (2016-2021e) & (K Pcs)
Table 99. South America Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (K Pcs)
Table 100. South America Metabotropic Glutamate Receptor 5 Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America Metabotropic Glutamate Receptor 5 Revenue by Country (2021-2026) & (USD Million)
Table 102. South America Metabotropic Glutamate Receptor 5 Sales by Type (2016-2021e) & (K Pcs)
Table 103. South America Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (K Pcs)
Table 104. South America Metabotropic Glutamate Receptor 5 Sales by Application (2016-2021e) & (K Pcs)
Table 105. South America Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (K Pcs)
Table 106. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Country (2016-2021e) & (K Pcs)
Table 107. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (K Pcs)
Table 108. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Type (2016-2021e) & (K Pcs)
Table 111. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (K Pcs)
Table 112. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Application (2016-2021e) & (K Pcs)
Table 113. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (K Pcs)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. Metabotropic Glutamate Receptor 5 Typical Distributors
Table 117. Metabotropic Glutamate Receptor 5 Typical Customers
List of Figures
Figure 1. Metabotropic Glutamate Receptor 5 Picture
Figure 2. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2020
Figure 3. Alloswitch-1
Figure 4. BMS-952048
Figure 5. BMS-955829
Figure 6. Dipraglurant ER
Figure 7. Others
Figure 8. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application in 2020
Figure 9. Major Depressive Disorder
Figure 10. Alcohol Addiction
Figure 11. Alzheimer's Disease
Figure 12. Others
Figure 13. Global Metabotropic Glutamate Receptor 5 Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 14. Global Metabotropic Glutamate Receptor 5 Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. Global Metabotropic Glutamate Receptor 5 Sales (2016-2026) & (K Pcs)
Figure 16. Global Metabotropic Glutamate Receptor 5 Price by Type (2016-2026) & (USD/Pcs)
Figure 17. Global Metabotropic Glutamate Receptor 5 Production Capacity (2016-2026) & (K Pcs)
Figure 18. Global Metabotropic Glutamate Receptor 5 Production Capacity by Geographic Region: 2020 VS 2021
Figure 19. Metabotropic Glutamate Receptor 5 Market Drivers
Figure 20. Metabotropic Glutamate Receptor 5 Market Restraints
Figure 21. Metabotropic Glutamate Receptor 5 Market Trends
Figure 22. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Manufacturer in 2020
Figure 23. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Manufacturer in 2020
Figure 24. Metabotropic Glutamate Receptor 5 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 25. Top 3 Metabotropic Glutamate Receptor 5 Manufacturer (Revenue) Market Share in 2020
Figure 26. Top 6 Metabotropic Glutamate Receptor 5 Manufacturer (Revenue) Market Share in 2020
Figure 27. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2016-2026)
Figure 28. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2016-2026)
Figure 29. North America Metabotropic Glutamate Receptor 5 Revenue (2016-2026) & (USD Million)
Figure 30. Europe Metabotropic Glutamate Receptor 5 Revenue (2016-2026) & (USD Million)
Figure 31. Asia-Pacific Metabotropic Glutamate Receptor 5 Revenue (2016-2026) & (USD Million)
Figure 32. South America Metabotropic Glutamate Receptor 5 Revenue (2016-2026) & (USD Million)
Figure 33. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue (2016-2026) & (USD Million)
Figure 34. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2016-2026)
Figure 35. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2016-2026)
Figure 36. Global Metabotropic Glutamate Receptor 5 Price by Type (2016-2026) & (USD/Pcs)
Figure 37. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2016-2026)
Figure 38. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2016-2026)
Figure 39. Global Metabotropic Glutamate Receptor 5 Price by Application (2016-2026) & (USD/Pcs)
Figure 40. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2016-2026)
Figure 41. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2016-2026)
Figure 42. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2016-2026)
Figure 43. North America Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2016-2026)
Figure 44. United States Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Canada Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Mexico Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2016-2026)
Figure 48. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2016-2026)
Figure 49. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2016-2026)
Figure 50. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2016-2026)
Figure 51. Germany Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2016-2026)
Figure 57. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2016-2026)
Figure 59. Asia-Pacific Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2016-2026)
Figure 60. China Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Korea Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2016-2026)
Figure 67. South America Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2016-2026)
Figure 68. South America Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2016-2026)
Figure 69. South America Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2016-2026)
Figure 76. Turkey Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Egypt Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. South Africa Metabotropic Glutamate Receptor 5 Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Buy
